Antiretroviral therapy: dolutegravir sets SAIL(ING)

被引：4

作者：

Boyd, Mark A. ^{[1
]}

Donovan, Basil ^{[1
]}

机构：

[1] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW 2052, Australia

来源：

LANCET | 2013年 / 382卷 / 9893期

关键词：

CO-FORMULATED ELVITEGRAVIR; HIV-1; INFECTION; DOUBLE-BLIND; INITIAL TREATMENT; CONTROLLED-TRIAL; RALTEGRAVIR; EMTRICITABINE; COBICISTAT; TENOFOVIR; EFAVIRENZ;

D O I：

10.1016/S0140-6736(13)61456-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：664 / 666

页数：3

共 10 条

[1]

Cahn P, 2013, LANCET

[2] Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial [J].

DeJesus, Edwin ;

Rockstroh, Juergen K. ;

Henry, Keith ;

Molina, Jean-Michel ;

Gathe, Joseph ;

Ramanathan, Srinivasan ;

Wei, Xuelian ;

Yale, Kitty ;

Szwarcberg, Javier ;

White, Kirsten ;

Cheng, Andrew K. ;

Kearney, Brian P. .

LANCET, 2012, 379 (9835) :2429-2438

[3] Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial [J].

Lennox, Jeffrey L. ;

Dejesus, Edwin ;

Lazzarin, Adriano ;

Pollard, Richard B. ;

Ramalho Madruga, Jose Valdez ;

Berger, Daniel S. ;

Zhao, Jing ;

Xu, Xio ;

Williams-Diaz, Angela ;

Rodgers, Anthony J. ;

Barnard, Richard J. O. ;

Miller, Michael D. ;

DiNubile, Mark J. ;

Nguyen, Bach-Yen ;

Leavitt, Randi ;

Sklar, Peter .

LANCET, 2009, 374 (9692) :796-806

[4] Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial [J].

Madruga, Jose Valdez ;

Cahn, Pedro ;

Grinsztejn, Beatriz ;

Haubrich, Richard ;

Lalezari, Jacob ;

Mills, Anthony ;

Pialoux, Gilles ;

Wilkin, Timothy ;

Peeters, Monika ;

Vingerhoets, Johan ;

de Smedt, Goedele ;

Leopold, Lorant ;

Trefiglio, Roberto ;

Woodfall, Brion .

LANCET, 2007, 370 (9581) :29-38

[5]

Nichols G, 2012, J INT AIDS SOC S4, V15, P18112

[6] Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study [J].

Raffi, Francois ;

Rachlis, Anita ;

Stellbrink, Hans-Juergen ;

Hardy, W. David ;

Torti, Carlo ;

Orkin, Chloe ;

Bloch, Mark ;

Podzamczer, Daniel ;

Pokrovsky, Vadim ;

Pulido, Federico ;

Almond, Steve ;

Margolis, David ;

Brennan, Clare ;

Min, Sherene .

LANCET, 2013, 381 (9868) :735-743

[7] Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks [J].

Sax, Paul E. ;

DeJesus, Edwin ;

Mills, Anthony ;

Zolopa, Andrew ;

Cohen, Calvin ;

Wohl, David ;

Gallant, Joel E. ;

Liu, Hui C. ;

Zhong, Lijie ;

Yale, Kitty ;

White, Kirsten ;

Kearney, Brian P. ;

Szwarcberg, Javier ;

Quirk, Erin ;

Cheng, Andrew K. .

LANCET, 2012, 379 (9835) :2439-2448

[8] Raltegravir with optimized background therapy for resistant HIV-1 infection [J].

Steigbigel, Roy T. ;

Cooper, David A. ;

Kumar, Princy N. ;

Eron, Joseph E. ;

Schechter, Mauro ;

Markowitz, Martin ;

Loutfy, Mona R. ;

Lennox, Jeffrey L. ;

Gatell, Jose M. ;

Rockstroh, Jurgen K. ;

Katlama, Christine ;

Yeni, Patrick ;

Lazzarin, Adriano ;

Clotet, Bonaventura ;

Zhao, Jing ;

Chen, Joshua ;

Ryan, Desmond M. ;

Rhodes, Rand R. ;

Killar, John A. ;

Gilde, Lucinda R. ;

Strohmaier, Kim M. ;

Meibohm, Anne R. ;

Miller, Michael D. ;

Hazuda, Daria J. ;

Nessly, Michael L. ;

DiNubile, Mark J. ;

Isaacs, Robin D. ;

Nguyen, Bach-Yen ;

Teppler, Hedy .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :339-354

[9] The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults [J].

Underwood, Mark R. ;

Johns, Brian A. ;

Sato, Akihiko ;

Martin, Jeffrey N. ;

Deeks, Steven G. ;

Fujiwara, Tamio .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (03) :297-301

[10]

Walmsley S, 2012, 52 INT C ANT CHEM SE

← 1 →